A lot of things to like here :
- stable adjusted EBITDA and and + 10 % for cash flow from operation* despite some sales decrease, excluding the impact of Holman acquisition,
- significant margin rebound in Americas,
- clear sales improvement during H2 vs H1 both in APAC and EMEA.
Their guidance for H1 25 looks also quite positive, expecting sales more or less flat and further margin improvement.
Valuation looks also OK to me with a free cash flow yield of 7 % (excluding growth capex).
* mainly due to working capital decrease.
A lot of things to like here :- stable adjusted EBITDA and and +...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.34 |
Change
0.140(3.33%) |
Mkt cap ! $3.364B | |||
| Open | High | Low | Value | Volume |
| $4.26 | $4.36 | $4.26 | $11.59M | 2.676M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 7686 | $4.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.34 | 18349 | 24 |
View Market Depth
| Last trade - 12.13pm 23/07/2025 (20 minute delay) ? |
| RWC (ASX) Chart |